NDTVHealth
GLP-1 Drugs Get New Warning Over Rare Blindness Risk
Medicines in the glucagon-like peptide one drug class will carry new warning labels about a rare risk of blindness. The order applies to every drug in the class, but no further details about the risk were provided.
This card is an AI-assisted summary of reporting published by NDTV. Read the original report before relying on it for medical, legal, financial, safety, or emergency decisions.